Atara Biotherapeutics (ATRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's ...

On a per-share basis, the Stamford, Connecticut-based company said it had net income of $1.94. The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks ...

Here are three stocks with buy rank and strong income characteristics for investors to consider today, October 16th: Two ...

TechTarget TTGT shares soared 10.6% in the last trading session to close at $27.83. The move was backed by solid volume with ...

COTY's Q1 LFL sales grow 4-5% below expectations, prompting moderate Q2 growth forecasts. Management is also ramping up its cost-reduction efforts.

Organic sales do not count the impacts of foreign exchange, acquisitions and divestitures. Brian Mulberry, client portfolio ...

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, October 15th: BRF S.A ...

The regional bank operator posted revenue of $810.1 million in the period. Its revenue net of interest expense was $466.7 million, also beating Street forecasts. Four analysts surveyed by Zacks ...

UnitedHealth Group kicked off another round of earnings calls for major health insurance companies Tuesday morning, when it ...

Johnson & Johnson expects full-year earnings in the range of $9.88 to $9.98 per share, with revenue in the range of $88.4 billion to $88.8 billion. This story was generated by Automated Insights ( ...